Degenerative Disease
Oncology·MeSH: Neoplasms
9 drugs in development·8 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| latozinemab | Alector, Inc. (ALEC) |
Phase 2(4)
Phase 1(1)
| Drug | Company |
|---|---|
| PRX019 | PROTHENA CORP PUBLIC LTD CO (PRTA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Degenerative Disease?
BioSniper tracks 9 drugs in development for Degenerative Disease across 8 companies.
How many clinical trials target Degenerative Disease?
There are 1 clinical trial targeting Degenerative Disease tracked by BioSniper.
Deep-dive into Degenerative Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis